The German chemicals giant is running a delicate balancing act: returning capital to shareholders at record scale while simultaneously re-routing supply chains around one of Europe’s most critical waterways. With the Rhine at historically low levels, BASF has been forced to shift freight from barges to trucks and rail at its sprawling Ludwigshafen complex, where roughly 40 percent of goods typically move by ship.
Investors, however, have yet to flinch. The stock closed Friday at €51.48, up 1.18 percent on the day and 8.04 percent higher over the past month. Since the start of 2025, the shares have gained 15.87 percent, leaving them just 6.49 percent shy of the 52-week high of €55.05 reached on April 14.
Low Water Levels Add Cost Pressure
The industry-wide alarm was sounded Thursday when the German Chemical Industry Association (VCI) warned of potential production cuts as low water levels hamper river traffic. The situation is acute: Cologne recently recorded its lowest water level since records began at 67 centimeters. For BASF, the logistical headache arrives at an awkward moment — just as the company hoped to build momentum from a strong second quarter.
Economist Stefan Kooths from the Kiel Institute for the World Economy estimates the low water could shave 0.1 to 0.2 percentage points off Germany’s third-quarter GDP, with the value-added loss roughly calculated at €1 billion to €2 billion. For BASF specifically, the added logistics costs represent a headwind that could pressure margins in the second half of the year.
A Quarter That Beat Expectations
The current share price strength traces back to July 29, when BASF published second-quarter figures that surprised to the upside. Revenue climbed to €17.206 billion from €14.788 billion in the year-earlier period — a jump of roughly 16 percent, supported by an 11.5 percent increase in prices and 7.3 percent higher volumes. EBITDA before special items surged more than 53 percent to €2.449 billion, comfortably beating both the €2.1 billion analyst consensus and the prior-year figure of €1.6 billion.
CEO Markus Kamieth credited progress across nearly all segments, citing stronger market positioning, restructuring advances, and portfolio development. Higher plant utilization, partly a result of supply disruptions in the Middle East, also contributed to the outperformance. Still, management cautioned that global economic uncertainties persist.
The strong results prompted BASF to raise its full-year guidance. The company now expects EBITDA before special items of €6.9 billion to €7.7 billion for 2026, up from a previous range of €6.2 billion to €7.0 billion. The free cash flow outlook remains unchanged at €1.5 billion to €2.3 billion.
Buyback Program Moves Into Higher Gear
Alongside the earnings release, BASF launched a new share repurchase program of up to €1.0 billion, which began in August and will run until the end of April 2027. The company can acquire a maximum of 77 million shares, which will subsequently be cancelled, reducing share capital accordingly.
Should investors sell immediately? Or is it worth buying BASF?
This tranche forms part of a broader €4 billion buyback program announced in September 2024 and scheduled to run through the end of 2028. Between November 2025 and June 2026, BASF had already repurchased shares worth approximately €1.5 billion, with 31,600,261 shares — around 3.5 percent of share capital — earmarked for cancellation.
The combination of an upgraded outlook and ongoing capital returns has resonated with the market. The stock has climbed 8.04 percent over the last 30 days and currently trades above both its 50-day average of €48.96 and its 200-day average, a technical signal that the upward trend remains intact. Since hitting a yearly low of €41.55 on October 14, 2025, the shares have advanced 23.90 percent.
Analysts Split on Sustainability
Reactions from the sell-side have been mixed, reflecting uncertainty about how durable the operational improvement truly is. UBS raised its price target from €52 to €55 on July 31 while keeping a Neutral rating, with analyst Christian Bell also lifting earnings estimates. Berenberg moved its target from €47 to €50 the same day, maintaining a Hold — analyst Sebastian Bray argued at the time that the stock was being driven more by macroeconomic factors than company-specific developments.
JPMorgan struck a notably more cautious tone, keeping its Underweight rating and €40 price target on July 29. The US bank pointed to one-off effects that had benefited the second quarter, questioning the sustainability of the earnings momentum. The resulting target range of €40 to €55 underscores the divergence of opinion. Shortly after the results were published, the shares briefly dipped 1.5 percent as the mixed analyst commentary filtered through.
Portfolio Reshaping Continues
Beyond the financial engineering, BASF has been actively streamlining its portfolio. Late June saw the closing of the Coatings business sale to Carlyle, following receipt of all regulatory approvals. Earlier, in March, the agricultural division finalized its acquisition of AgBiTech. Both transactions fit a broader strategy of sharpening the portfolio while freeing up capital for buybacks and investment.
Management changes have also been in motion: Mary Kurian and Livio Tedeschi joined the executive board on May 1, following Michael Heinz’s planned retirement on April 30.
The next major milestone for investors arrives on October 27, when BASF reports third-quarter numbers. By then, the market will have a clearer picture of whether the Rhine’s low water levels have begun to bite into margins — and whether the buyback has provided the technical support that many expect. For now, the shares sit comfortably above their key moving averages, with the buyback running in the background and the portfolio story gaining clarity.
Ad
BASF Stock: Buy or Sell?! New BASF Analysis from August 9 delivers the answer:
The latest BASF figures speak for themselves: Urgent action needed for BASF investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 9.
BASF: Buy or sell? Read more here...
